Rockets and Duds: Week 17 - April 28, 2025

Chris White Apr 28, 2025
Headline image for Rockets and Duds: Week 17 - April 28, 2025

5i Research Weekly Rockets and Duds

This week's 5i Research Rockets 🚀🚀🚀 and Duds 🚫🚫🚫

It was a big rally week for the stock market, and we had 17 stocks to choose from whose shares rose more than 30%. We have three rockets and two duds in this week's 5i Research Rockets and Duds report


 

Novagold NG 🚀🚀🚀 The gold explorer rose 49% as gold extended its rally but also with a big acquisition. Novagold and billionaire John Paulson agreed to buy 50% of the Donlin Gold Project in Alaska from Barrick Gold. The deal gives Novagold more control of the project. It could produce more than one million ounces of gold, if the mine can ever be built. Novagold has worked towards production for decades, and has been met with opposition from several groups and the project has been on again, off again like a light switch. But money talks, and gold is surging. Maybe there will be a new mine in Alaska one day. 
 
WeBull Corporation BULL 🚫🚫🚫 How does a stock with the symbol "BULL" manage to drop 34% during a big stock market rally week? WeBull, a financial services company offering digital investment platforms for trading, wealth management and distribution, fell sharply, going the opposite way of the market. But don't feel too bad for the company: Earlier in April, shares rose 374% in a single day following the company's listing. Shares peaked at $79.56, and are now $17.27. That's a big hit, but with the initial price at $13.25, that's still BULLish for most investors. Market cap is now $6 billion. 
 
Bitdeer Technologies Group BTDR 🚀🚀🚀 Ahh, crypto currencies, they are so much fun. Bitdeer shares rose 38% last week as it secured a $200 million credit facility to support expansion of its global bitcoin mining operations. The big move comes three months after Bitdeer acquired a 101-megawatt data centre near Fox Creek, Alberta. Don't get too excited by the big rally, though: shares are still down 51% in 2025. 
 
Grail Inc. GRAL 🚀🚀🚀 We are not sure why everyone struggles with the stock market, when the Holy Grail of stocks is staring you right in the eye, and anyone can buy it. Grail, a cancer and blood testing company, rose 38% last week, on the back of good earnings and good guidance. Shares are now up 108% for the year. It's not rocket science, people, it's MEDICAL science. 
 
SAIA Inc. SAIA 🚫🚫🚫 Don't worry, tariffs will make America Great Again. SAIA shareholders might have an opposing view, however, with shares down 26% last week on news that tariffs are 'tanking' demand at the trucking company. Growth last year was helped as a competitor, Yellow Corp., went bankrupt, and SAIA bought 28 terminals from Yellow. But this year, a different colour (yes, Orange, as in Trump's hair) is giving it problems. 
Take Care,

Peter's Signature


Unlock the Power of Informed Investing with 5i Research!

DIY investing doesn't have to mean going it alone. At 5i Research, we're your trusted partner in navigating the stock market. Our platform offers comprehensive stock and market research, empowering you to make smart investment decisions. 

  • Investor Q&A: Have burning questions? Get answers from our team of experts and fellow investors in our dedicated Q&A section.
  • Research Reports: With over 60 meticulously researched Canadian stocks, our reports offer in-depth analysis, giving you the confidence to invest wisely. 
  • Model Portfolios, Alerts, Forums, Portfolio Tracking, and Much More...


 

Analysts of 5i Research responsible for this report do not have a financial or other interest in securities mentioned. The i2i Fund does not have a financial or other interest in securities mentioned.

0 comments

Comments

Login to post a comment.

No comments have been posted yet.